Cargando…
Maintenance of Blinding in Clinical Trials and the Implications for Studying Analgesia Using Cannabinoids
The design of analgesic clinical trials invariably involves a comparison between placebo and active study medication. An assumption is made that treatment effects can be approximated by subtracting the response to placebo from that attained with the use of active study medication. However, the psych...
Autores principales: | Wilsey, Barth, Deutsch, Reena, Marcotte, Thomas D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549444/ https://www.ncbi.nlm.nih.gov/pubmed/28861490 http://dx.doi.org/10.1089/can.2016.0016 |
Ejemplares similares
-
A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis
por: Wilsey, Barth L, et al.
Publicado: (2016) -
Implications for blinding in clinical trials with THC-containing cannabinoids based on the CANNA-TICS trial
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2022) -
Involvement of cannabinoid type 1 receptor in fasting-induced analgesia
por: Lee, Jeong-Yun, et al.
Publicado: (2020) -
Cannabinoids: Therapeutic Use in Clinical Practice
por: Pagano, Cristina, et al.
Publicado: (2022) -
A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis—Clinical Implications
por: Wołyniak, Maria, et al.
Publicado: (2022)